A small double blind study of Prozac therapy for multiple sclerosis has concluded with a reduction of neurological inflammation for the group recieving the active medication. The results suggest further study.
Your email is never published nor shared. Required fields are marked *
You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
Prozac Limits Lesions
A small double blind study of Prozac therapy for multiple sclerosis has concluded with a reduction of neurological inflammation for the group recieving the active medication. The results suggest further study.